Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion type Assertion NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_head.
- NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion description "[We developed a comprehensive model of acquired resistance to ROS1 inhibitors in NSCLC with ROS1 rearrangement and identified cabozantinib as a therapeutic strategy to overcome the resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_provenance.
- NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion evidence source_evidence_literature NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_provenance.
- NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion SIO_000772 25351743 NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_provenance.
- NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion wasDerivedFrom befree-2016 NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_provenance.
- NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_assertion wasGeneratedBy ECO_0000203 NP1233258.RA0-pJciJ-PESXlrM_Rd9dePDWkcr4AdkVkEqhtFVrwsY130_provenance.